-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RYtgHCJ86VRghODN7kwddsn0FYa2PWRsHNcGgKRgOpVrYR7xfNP3n4FXfiq/I6ej JW+vlC2Z1HPxrsiD4pfHlg== 0001181431-05-060439.txt : 20051109 0001181431-05-060439.hdr.sgml : 20051109 20051109135915 ACCESSION NUMBER: 0001181431-05-060439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051029 FILED AS OF DATE: 20051109 DATE AS OF CHANGE: 20051109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAYS PAUL RICHARD CENTRAL INDEX KEY: 0001213640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11303 FILM NUMBER: 051189148 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 8584513771 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNBIOTICS CORP CENTRAL INDEX KEY: 0000719483 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953737816 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 8584513771 MAIL ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 4 1 rrd96777.xml FORM 4 X0202 4 2005-10-29 0 0000719483 SYNBIOTICS CORP SBIO 0001213640 HAYS PAUL RICHARD 11011 VIA FRONTERA SAN DIEGO CA 92127 1 1 0 0 President Common stock 2005-10-29 4 J 0 1249 0.13 D 24000 D Common stock option 2005-03-30 2014-12-30 Common Stock 2400000 2400000 D Series C Preferred Stock Common Stock 778452 778452 D On October 29, 2005, Synbiotics Corporation effected a reverse stock split of its common stock in the ratio of 1-for-2,000. Any fractional share resulting from the reverse split was cashed out by Synbiotics Corporation in the amount of $0.13 for each pre-reverse-split share of common stock which became part of a fractional share. Mr. Hays received $162.37 for 1,249 pre-reverse-split shares of common stock which became part of a fractional share. On October 30, 2005, Synbiotics Corporation effected a forward stock split of its common stock in the ratio of 2,000-for-1. The options, which vest quarterly over four (4) years, have exercise prices ranging from $0.08 per share to $0.34 per share On September 23, 2004, Mr. Hays purchased 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. The shares are convertible into shares of common stock at any time into such number of shares of common stock by dividing each share of Series C Convertible Preferred Stock, valued at $1,000, by the conversion price - initially set at $0.12846. Paul R. Hays, by Keith A. Butler his attorney-in-fact 2005-11-09 -----END PRIVACY-ENHANCED MESSAGE-----